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Matters Arising
sequent fluorography of two independent experiments re-Arginine Methylation of STAT1:
vealed methylation of several proteins but not of STAT1A Reassessment (Figure 2 and Supplemental Figure S2).
Mowen et al. used an R31A mutant to mimic STAT1
methylation. We examined the mutant in a STAT1-nega-
tive background and found loss of function in contrast
to authors of the Mowen et al. study who used cells
expressing endogenous STAT1 and reported gain ofAn intriguing model was proposed stating that arginine
function (Supplemental Figure S3; Shuai et al., 1996).31 methylation of STAT1 enhances its DNA binding by
We discovered that the IFN-induced association withreducing association with the specific inhibitor PIAS1,
Importin-5 required a conserved STAT1 N domain ofthus intensifying the growth-restraining activities of the
130 residues (Figure 3A), explaining previously reportedinterferons (Mowen et al., 2001). This finding may explain
nuclear translocation defects (Strehlow and Schindler,the interferon (IFN) insensitivity of cancer cells that accu-
1998). Alanine mutation of single (E29, R70, E111) or multiplemulate high levels of the methyltransferase inhibitor
surface residues ([H81, R84, K85, R88][K110, E111, R113, K114]) inmethylthioadenosine (MTA).
the N domain, which itself is devoid of transport activityMowen et al. used monoclonal antibodies against di-
(Begitt et al., 2000), did not affect nuclear import (datamethylarginine for immunoprecipitations to demon-
not shown), indicating an unconventional nuclear tar-strate methylation of STAT1 in vivo. However, coprecipi-
geting function. In contrast, mutations affecting a buriedtation with a methylated protein could not be excluded
invariant salt bridge network (W4, W37, E39, E112, Vinke-and the antibody did not function in Western blots to
meier et al., 1998) grouped around R31 (including muta-confirm the modification on STAT1 (Mowen and David,
tion of R31 to A or K) abolished IFN-induced nuclear2001). Thus, this approach does not prove STAT1 meth-
import (Supplemental Figures S4 and S5). Moreover,ylation, let alone differences in STAT1 methylation stoi-
these mutations caused N-terminal degradation and de-chiometry. Additionally, the authors reported mass
fective dephosphorylation (Supplemental Figure S6), an-spectrometry (MS) without providing sequencing data
other malfunction seen also after amino-terminal dele-for peak identification and without negative controls.
tions (Supplemental Figure S6). Fusion of STAT1-R31AWe performed three independent MS analyses using
to GST, a stabilized derivative used by Mowen et al.,Strep-tagged STAT1 that was purified from stably trans-
neither remedied defective dephosphorylation (Shuai etfected U3A cells (a STAT1-negative derivative of the cell
al., 1996) nor restored nuclear import (Figure 3B). Weline used by Mowen et al. in their Figure 2B), and the
results were identical irrespective of IFN treatment of
cells (for methods, see Supplemental Data at http://
www.cell.com/cgi/content/full/119/5/587/DC1/). The
MALDI spectra obtained with STAT1 after AspN cleav-
age, which yielded peptides with masses identical to those
reported by Mowen et al., revealed singly charged mass
peaks at m/z 1319.7 and m/z 1704.9, corresponding to
the unmodified STAT1 fragments 29EIRQYLAQWL38 and
29EIRQYLAQWLEKQ41 (one missed cleavage), respec-
tively (Figure 1A). Mass peaks which would match with
R31-methylated sequences (14 mass units per methyl
group) were not present. The amino acid sequences of
the unmodified peptides were confirmed by nanoLC-
ESI-MS/MS (Supplemental Figure S1 online). In addition,
we synthesized R31-unmethylated (m/z 1319.8 and 1709.9)
and R31-dimethylated (28 mass units) peptides corre-
sponding to the mentioned AspN fragments of STAT1.
MALDI and ESI measurements (Figure 1B and Supple-
mental Figure S1 online) yielded comparable ion intensi-
ties irrespective of methylation, thus excluding the pos-
sibility that methylated peptides went undetected due
to insufficient ionization. Considering the optimal peak
intensities and the excellent signal-to-noise ratio of our
Figure 1. MALDI Mass Analyses of STAT1 R31 MethylationMS analyses with the native material, we concluded that
(A) Peaks with m/z 1319.71 and 1704.91 correspond to the unmodi-STAT1 is not methylated at R31 to a significant extent.
fied AspN fragments 29–38 and 29–41, respectively. STAT1 wasBased on the premise of rapid methyl turnover in IFN-
purified from U3A cells.
treated HeLa cells made by Mowen et al., such cells were (B) Peaks with m/z 1319.8 and 1347.9 correspond to the unmodified
metabolically labeled for 3 hr by using L-[methyl-3H]- and R31-dimethylated AspN fragment 29–38, respectively. An equi-
molar mixture of synthetic peptides was used.methionine before STAT1 was immunoprecipitated. Sub-
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Figure 4. MTA Inhibits Tyrosine Phosphorylation of STAT1
MCF-7 cells were incubated for 3 hr with medium containing carrier
(DMSO) or MTA (0.3 mM). Subsequently, the cells were left untreated
or stimulated with IFN or - for 30 min as indicated. Shown are
Western blot results of whole-cell extracts with antibodies against
tyrosine-phosphorylated STAT1 (-Y701P) or total STAT1 (-STAT1).
concluded that mutation of R31 destabilized and inacti-
vated the N domain.
According to Mowen et al., inhibitory effects on
IFN-induced transcription of the methyltransferase in-Figure 2. Absence of Methylation of STAT1
hibitor MTA can be attributed specifically to the reducedHeLa cells were incubated with the methyl donor L-[methyl-3H]methi-
onine in the presence of protein synthesis inhibitors. The gel was arginine methylation of STAT1. Yet, MTA has been shown
loaded with 1% of the whole-cell extract (W) or the immunoprecipi- to adversely affect a variety of biological processes (Wil-
tate obtained with a STAT1-specific antibody (IP). Shown is the liams-Ashman et al., 1982), as evidenced by its influence
methylation pattern as determined by fluorography after 2 weeks on numerous enzymatic reactions. Used at the concen-
exposure.
tration reported by Mowen et al., it considerably dimin-
ished the IFN-induced tyrosine phosphorylation of
STAT1 (Figure 4). This was seen for several cell lines,
various MTA concentrations, and even in the absence
of the STAT1 N domain, thus ruling out the participation
of R31 (Supplemental Figures S7A and S7B). The propor-
tionate decrease in DNA binding activity provides a sim-
ple explanation for the reduced transcriptional activity
of STAT1 during MTA treatment (Supplemental Figures
S7C and S7D). Analogous observations were made also
for STAT6 (Chen et al., 2004). In addition, we found that
MTA inhibited also the dephosphorylation of the kinase
p38, and MTA strongly reduced transcription of a
STAT1-independent NF-B reporter gene (Supplemen-
tal Figure S8).
In summary, our examination provided evidence that
contradicts previous results that stated methylation of
arginine 31. Thus, alternative explanations to STAT1
methylation need to be explored in order to understand
the molecular mechanisms that underlie the reduced
interferon sensitivity of many tumor cells.
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Figure 3. Mutations Affecting the N Domain Structure Preclude Nu- 2 AG Massenspektrometrie
clear Import of STAT1 Leibniz-Forschungsinstitut fu¨r Molekulare
(A) Lysates from IFN-treated U3A cells expressing STAT1-GFP fu- Pharmakologie
sion proteins (WT, wild-type; N, STAT1 lacking residues 1–126; Freie Universita¨t Berlin
KK/EE, import mutant KK410/413 to EE; Meyer et al., 2002) were
13125 Berlinnormalized with respect to tyrosine-phosphorylated STAT1 (input)
Germanyand incubated with sepharose-immobilized GST-Importin-5. Tyro-
sine-phosphorylated STAT1 in the input and bound to Importin-5
Selected Readingwas detected by Western blotting.
(B) HeLa cells transiently expressing wild-type or R31A mutant
Begitt, A., Meyer, T., van Rossum, M., and Vinkemeier, U. (2000).STAT1-GFP fused to the C terminus of GST were left untreated or
Proc. Natl. Acad. Sci. USA 97, 10418–10423.stimulated with IFN or - for 60 min. GST-STAT1 was detected in
fixed cells by GFP fluorescence. IFN stimulation was performed in Chen, W., Daines, M.O., and Hershey, G.K. (2004). J. Immunol.
172, 6744–6750.HeLa cells that additionally coexpressed Tyk2 and IFN receptor 1.
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Figure 1. Effect of MTA on STAT1 Tyrosine Phosphorylation
MTA was dissolved either in DMSO or directly in tissue culture
medium. MTA was added to the cells 1 hr prior to stimulation with
IFN (1,000 u/ml) for 30 min. Cell lysates were probed with p(Y701)S-Response to Matters Arising
TAT1 or STAT1 antisera.
to our findings. The authors further state that “… the
same observations were also made for STAT6 (Chen et
al., 2004).” Meissner et al. incubated the cells with MTAIn their Matters Arising article, Meissner et al. present
several experiments that call into question our conclu- in DMSO, whereas we had solubilized MTA in tissue
culture media. While somewhat unexpected, this differ-sions from the results reported in our original manuscript
(Mowen et al., 2001). We clearly acknowledge the impor- ence in solvents used seems to make a significant differ-
ence (see Figure 1): when dissolved in DMSO, MTA doestance of these new findings, but at the same time have
reservations about the extent to which these results indeed block STAT1 tyrosine phosphorylation. However,
when MTA is dissolved in media (as was done in ourinvalidate our conclusions of STAT1 arginine methyl-
ation. original studies to completely block IFN/-mediated
ISG induction), no inhibition of STAT1 tyrosine phos-We had employed monoclonal antibodies against di-
methylarginine (DMA) to demonstrate methylation of phorylation is observed. While we cannot offer an expla-
nation for these different, solvent-dependent effects ofSTAT1 in vivo. Since the antibody was ineffective in
Western blots, we performed immunoprecipiations, fol- MTA, the finding nevertheless invalidates the notion that
mere inhibition of STAT1 tyrosine phosphorylation ac-lowed by anti-STAT1 immunoblotting. Specificity of the
antibodies was demonstrated by the fact that only a counts for the inhibitory effects of MTA on IFN/-induced
gene transcription. In addition, the paper reportingmethylated STAT1 N-terminal domain could success-
fully compete for binding to the DMA antibody. Other STAT6 arginine methylation quoted in this context by
the authors clearly shows that STAT6, but not STAT1labs have in the meantime reproduced these findings
for STAT1, STAT3, and STAT6 (Chen et al., 2004; Duong tyrosine phosphorylation is inhibited by the methyltrans-
ferase inhibitors (Chen et al., 2004: Figure 6B). Lastly,et al., 2004; Rho et al., 2001). However, despite the use
of high-stringent immunoprecipitation condition, coim- MTA-mediated inhibition of STAT1 tyrosine phosphory-
lation cannot explain the increased PIAS associationmunoprecipitation of STAT proteins with associated, ar-
ginine-methylated proteins can naturally not be defini- with hypomethylated STAT1 we and others have ob-
served (Duong et al., 2004). The fact that MTA alsotively excluded in these experiments. However, Rho et
al. reported the arginine methylation of STAT3 (Rho et blocks an NF-B luciferase does not justify the conclu-
sion that it is a nonspecific transcriptional inhibitor. Theal., 2001). This study not only used the DMA antibody
for immunoprecipitation followed by STAT3 Western inhibitory effect of MTA on LPS-mediated NF-B activa-
tion has been previously reported; however, the sameblotting but also successfully employed the DMA anti-
body for Western blotting of STAT3 immunoprecipitates paper provides clear evidence for significantly increased
IL-10 production under these conditions (Hevia et al.,to demonstrate STAT3 arginine methylation (Rho et al.,
2001, Figure 2). 2004). We have also shown in our manuscript that c-fos
induction by serum is not affected by MTA. Lastly, in aIn the metabolic labeling experiments using L-[methyl-
3H]methionine, the incorporation of radioisotope is not follow-up paper published in 2002 we had used different
methylation inhibitors, which like MTA caused abroga-restricted to arginine residues, as lysines as well as
COOH termini can also be methylated. It would therefore tion of IFN/-induced transcription without blocking
STAT1 tyrosine phosphorylation (Zhu et al., 2002).be helpful to know whether the authors were able to
detect radioisotope incorporation into other proteins Our own mass spectrometry data, which had iden-
tified peptides of the appropriate molecular massknown to be arginine methylated on a single residue
(e.g., Sam68, CBP, EWS). (Supplemental Figure S1 at http://www.cell.com/cgi/
content/full/119/5/589/DC1/), and the concurring resultsDr. Vinkemeier’s group further reports that in their
hands the methylation inhibitor MTA blocks tyrosine we had obtained from the mutational analysis of STAT1
R31 may have mislead us into the conclusion that R31phosphorylation of STAT1, which is in striking contrast
